Comprehensive diagnostics

A planned step beyond single-condition lab tests toward wider whole-body testing, used to guide prescriptions and ongoing care. Its scope, pricing and timing have not been broken out in company disclosures.

Why it matters to the stock. If diagnostics become a paid tier across the subscriber base, they could lift revenue per subscriber. Until the company reports numbers, the effect is hard to size.